Ra Medical Systems, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Indemnification Agreements (1 contract)
- Marketing Agreements (3)
- Sales Agreements (1)
- Services Agreements (3)
- Settlement Agreements (4)
- Addendum One dated May 27, 2022 to the Stereotaxis Marketing Agreement (Filed With SEC on March 28, 2023)
- Extension Agreement dated January 11, 2022 to the Stereotaxis Marketing Agreement (Filed With SEC on March 28, 2023)
- Joint Marketing Agreement dated January 19, 2021 with Stereotaxis, Inc. (the Stereotaxis Marketing Agreement) (Filed With SEC on March 28, 2023)
- Debt Settlement Agreement and Release including certain royalty rights with Fatboy Capital, L.P., dated January 9, 2023 (Filed With SEC on March 28, 2023)
- Debt Settlement Agreement and Release including certain royalty rights with Daniel C. Stanzione, Sr. Irrevocable Trust Dated December 31, 2007, dated January 9, 2023 (Filed With SEC on March 28, 2023)
- Debt Settlement Agreement and Release including certain royalty rights with David A. Jenkins, dated January 9, 2023 (Filed With SEC on March 28, 2023)
- At Market Issuance Sales Agreement by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 2, 2022)
- Services Agreement, dated August 16, 2021, by and between Ra Medical Systems, Inc. and Strata Skin Sciences, Inc (Filed With SEC on November 15, 2021)
- Services Agreement, dated August 16, 2021 by and between Ra Medical Systems, Inc. and Strata Skin Sciences, Inc (Filed With SEC on August 16, 2021)
- Corporate Integrity Agreement, between the Company and the Office of Inspector General of the Department of Health and Human Services, dated December 28, 2020 (Filed With SEC on March 17, 2021)
- Settlement Agreement, among the Company, among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector... (Filed With SEC on March 17, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on August 24, 2018)
